Page last updated: 2024-11-02

oxidopamine and Glucose Intolerance

oxidopamine has been researched along with Glucose Intolerance in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morris, JK1
Seim, NB1
Bomhoff, GL1
Geiger, PC1
Stanford, JA1

Other Studies

1 other study available for oxidopamine and Glucose Intolerance

ArticleYear
Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats.
    Neuroscience letters, 2011, Oct-31, Volume: 504, Issue:3

    Topics: Aging; Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Eating; Glucose Intolerance; Glucos

2011